Atlas Trials

Relapsed or Refractory T-cell Lymphomas

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory T-cell Lymphomas

RecordFirmDate
A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3) (NCT06035497)Bristol-Myers Squibb2023-11-20

Track Relapsed or Refractory T-cell Lymphomas automatically

Every clearance here is in the API, with alerts when new ones post.